Medpace Holdings [MEDP] vs Thermo Fisher [TMO] Detailed Stock Comparison

Medpace Holdings

NASDAQ
Loading...

Thermo Fisher

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Medpace Holdings wins in 7 metrics, Thermo Fisher wins in 12 metrics, with 0 ties. Thermo Fisher appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricMedpace HoldingsThermo FisherBetter
P/E Ratio (TTM)39.5631.46Thermo Fisher
Price-to-Book Ratio86.574.06Thermo Fisher
Debt-to-Equity Ratio86.9369.62Thermo Fisher
PEG Ratio3.645.54Medpace Holdings
EV/EBITDA29.7421.64Thermo Fisher
Profit Margin (TTM)18.74%15.24%Medpace Holdings
Operating Margin (TTM)20.94%17.84%Medpace Holdings
EBITDA Margin (TTM)20.94%17.84%Medpace Holdings
Return on Equity89.39%13.42%Medpace Holdings
Return on Assets (TTM)17.09%4.97%Medpace Holdings
Free Cash Flow (TTM)$572.27M$7.27BThermo Fisher
Dividend YieldN/A0.31%N/A
1-Year Return52.42%-8.87%Medpace Holdings
Price-to-Sales Ratio (TTM)6.704.75Thermo Fisher
Enterprise Value$15.06B$234.09BThermo Fisher
EV/Revenue Ratio6.755.42Thermo Fisher
Gross Profit Margin (TTM)29.84%40.61%Thermo Fisher
Revenue per Share (TTM)$74$114Thermo Fisher
Earnings per Share (Diluted)$13.46$17.27Thermo Fisher
Beta (Stock Volatility)1.410.78Thermo Fisher
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Medpace Holdings vs Thermo Fisher Stock Performance Analysis

Loading Price Chart...

Medpace Holdings
Thermo Fisher
Medpace Holdings Stock Overview | Thermo Fisher Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medpace Holdings-0.41%5.90%7.76%66.29%82.80%58.42%
Thermo Fisher0.12%17.73%11.55%29.91%24.23%4.09%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medpace Holdings52.42%246.47%328.56%1,791.23%1,791.23%1,791.23%
Thermo Fisher-8.87%8.13%16.08%330.34%1,014.88%1,684.61%

News Based Sentiment: Medpace Holdings vs Thermo Fisher

Medpace Holdings

News based Sentiment: MIXED

Medpace is showing strong financial performance with increased institutional investment and positive guidance, but faces a recent analyst downgrade and a relatively high valuation. The combination of positive and negative developments creates a mixed investment picture for the month.

View Medpace Holdings News Sentiment Analysis

Thermo Fisher

News based Sentiment: POSITIVE

Thermo Fisher Scientific demonstrated a strong month with strategic acquisitions (Solventum's purification business for $4.1 billion and Sanofi's sterile fill-finish site), innovative product launches, and positive financial results exceeding expectations in Q2 2025. This, combined with optimistic guidance, signals a positive trajectory for the company and strengthens the investment case.

View Thermo Fisher News Sentiment Analysis

Performance & Financial Health Analysis: Medpace Holdings vs Thermo Fisher

MetricMEDPTMO
Market Information
Market Cap i$14.96B$206.14B
Market Cap CategoryLarge capMega cap
10 Day Avg. Volume i278,9803,290,780
90 Day Avg. Volume i314,9432,194,303
Last Close$530.30$543.95
52 Week Range$250.05 - $547.15$385.46 - $610.97
% from 52W High-3.08%-10.97%
All-Time High$547.15 (Oct 01, 2025)$672.34 (Dec 27, 2021)
% from All-Time High-3.08%-19.10%
Growth Metrics
Quarterly Revenue Growth0.14%0.03%
Quarterly Earnings Growth0.02%0.05%
Financial Health
Profit Margin (TTM) i0.19%0.15%
Operating Margin (TTM) i0.21%0.18%
Return on Equity (TTM) i0.89%0.13%
Debt to Equity (MRQ) i86.9369.62
Cash & Liquidity
Book Value per Share (MRQ)$6.15$133.77
Cash per Share (MRQ)$1.65$16.92
Operating Cash Flow (TTM) i$614.10M$7.58B
Levered Free Cash Flow (TTM) i$445.14M$5.18B
Dividends
Last 12-Month Dividend Yield iN/A0.31%
Last 12-Month Dividend iN/A$1.21

Valuation & Enterprise Metrics Analysis: Medpace Holdings vs Thermo Fisher

MetricMEDPTMO
Price Ratios
P/E Ratio (TTM) i39.5631.46
Forward P/E i42.6323.13
PEG Ratio i3.645.54
Price to Sales (TTM) i6.704.75
Price to Book (MRQ) i86.574.06
Market Capitalization
Market Capitalization i$14.96B$206.14B
Enterprise Value i$15.06B$234.09B
Enterprise Value Metrics
Enterprise to Revenue i6.755.42
Enterprise to EBITDA i29.7421.64
Risk & Other Metrics
Beta i1.410.78
Book Value per Share (MRQ) i$6.15$133.77

Financial Statements Comparison: Medpace Holdings vs Thermo Fisher

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)MEDPTMO
Revenue/Sales i$558.57M$10.36B
Cost of Goods Sold i$380.22M$6.13B
Gross Profit i$178.35M$4.24B
Research & Development iN/A$342.00M
Operating Income (EBIT) i$113.52M$1.82B
EBITDA i$120.45M$2.73B
Pre-Tax Income i$118.17M$1.62B
Income Tax i$3.58M$95.00M
Net Income (Profit) i$114.60M$1.51B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)MEDPTMO
Cash & Equivalents i$441.44M$4.13B
Total Current Assets i$821.44M$23.38B
Total Current Liabilities i$1.12B$13.17B
Long-Term Debt i$126.66M$31.37B
Total Shareholders Equity i$593.61M$49.49B
Retained Earnings i$-269.72M$54.45B
Property, Plant & Equipment i$258.19MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)MEDPTMO
Operating Cash Flow i$166.55M$2.15B
Capital Expenditures i$-9.99M$-350.00M
Free Cash Flow i$115.84M$361.00M
Debt Repayment iN/A$-838.00M
Common Stock Repurchase i$-371.90M$-2.00B

Short Interest & Institutional Ownership Analysis

MetricMEDPTMO
Shares Short i2.20M3.83M
Short Ratio i6.812.34
Short % of Float i0.10%0.01%
Average Daily Volume (10 Day) i278,9803,290,780
Average Daily Volume (90 Day) i314,9432,194,303
Shares Outstanding i30.63M380.77M
Float Shares i22.25M376.74M
% Held by Insiders i0.21%0.00%
% Held by Institutions i0.97%0.92%

Dividend Analysis & Yield Comparison: Medpace Holdings vs Thermo Fisher

MetricMEDPTMO
Last 12-Month Dividend iN/A$1.21
Last 12-Month Dividend Yield iN/A0.31%
3-Year Avg Annual Dividend iN/A$1.33
3-Year Avg Dividend Yield iN/A0.07%
3-Year Total Dividends iN/A$3.99
Ex-Dividend DateN/AMar 14, 2025